Literature DB >> 1864006

An abnormal T cell repertoire in hypergammaglobulinaemic primary Sjögren's syndrome.

R A Kay1, E M Hay, P A Dyer, C Dennett, L M Green, R M Bernstein, P J Holt, R S Pumphrey, A W Boylston, W E Ollier.   

Abstract

T cell antigen specificity is determined by the products of the genes which encode the variable regions of their receptors. Of the T cell receptor (TCR) variable region gene products examined, only V beta 6.7a TCR-positive lymphocytes were reduced in primary Sjögren's syndrome patients with IgG1 hypergammaglobulinaemia compared with an age-, sex- and HLA-matched control population. The levels of V beta 6.7a T cells were also significantly reduced when these patients were compared with an age- and sex-matched but HLA-unmatched control group and non-tissue typed normal people of both sexes. Since published studies show no such abnormality in rheumatoid arthritis, systemic lupus erythematosus or other autoimmune diseases, this abnormality may reflect a pathogenic process specific to primary Sjögren's syndrome.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1864006      PMCID: PMC1535764          DOI: 10.1111/j.1365-2249.1991.tb05715.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  15 in total

Review 1.  Central MHC genes, IgA deficiency and autoimmune disease.

Authors:  M A French; R L Dawkins
Journal:  Immunol Today       Date:  1990-08

2.  Clinical, serological, and HLA phenotype subsets in Sjögren's syndrome.

Authors:  C T Pease; W Shattles; P J Charles; P J Venables; R N Maini
Journal:  Clin Exp Rheumatol       Date:  1989 Mar-Apr       Impact factor: 4.473

3.  Selective polyclonal increase of immunoglobulin G1 subclass: a link with Sjögren's syndrome.

Authors:  E M Hay; A J Freemont; R A Kay; R M Bernstein; P J Holt; R S Pumphrey
Journal:  Ann Rheum Dis       Date:  1990-06       Impact factor: 19.103

4.  Polymorphism of the T cell receptor beta-chain in Graves' disease.

Authors:  A Demaine; K I Welsh; B S Hawe; N R Farid
Journal:  J Clin Endocrinol Metab       Date:  1987-10       Impact factor: 5.958

Review 5.  HLA and T-cell receptor genes in insulin-dependent diabetes mellitus.

Authors:  M L Hoover; J D Capra
Journal:  Diabetes Metab Rev       Date:  1987-07

Review 6.  The control of antibody production by immunomodulatory molecules.

Authors:  P E Lipsky
Journal:  Arthritis Rheum       Date:  1989-11

7.  An IgG subclass imbalance in connective tissue disease.

Authors:  R A Kay; K J Wood; R M Bernstein; P J Holt; R S Pumphrey
Journal:  Ann Rheum Dis       Date:  1988-07       Impact factor: 19.103

8.  Activation of peripheral blood lymphocytes in patients with primary Sjögren's syndrome.

Authors:  P Youinou; Y L Pennec; M A Blaschek; A Gentric; J Jouquan; A Lamour; P Angelidis
Journal:  Rheumatol Int       Date:  1988       Impact factor: 2.631

9.  Evidence that matching for HLA antigens significantly increases transplant survival in 1001 renal transplants performed in the northwest region of England.

Authors:  P A Dyer; R W Johnson; S Martin; A Bakran; R Gokal; R Harris; N P Mallick; J Manos; W M Orr; R C Pearson
Journal:  Transplantation       Date:  1989-07       Impact factor: 4.939

10.  Association of membranous nephropathy with T-cell receptor constant beta chain and immunoglobulin heavy chain switch region polymorphisms.

Authors:  A G Demaine; R W Vaughan; D H Taube; K I Welsh
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

View more
  1 in total

1.  Single-cell analysis of glandular T cell receptors in Sjögren's syndrome.

Authors:  Michelle L Joachims; Kerry M Leehan; Christina Lawrence; Richard C Pelikan; Jacen S Moore; Zijian Pan; Astrid Rasmussen; Lida Radfar; David M Lewis; Kiely M Grundahl; Jennifer A Kelly; Graham B Wiley; Mikhail Shugay; Dmitriy M Chudakov; Christopher J Lessard; Donald U Stone; R Hal Scofield; Courtney G Montgomery; Kathy L Sivils; Linda F Thompson; A Darise Farris
Journal:  JCI Insight       Date:  2016-06-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.